Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

FDA Approves BioMarin's Batten Disease Drug. Cost Per Year is $702,000
FDA Approves BioMarin's Batten Disease Drug. Cost Per Year is $702,000
Following the FDA approval of Brineura (cerliponase alfa), BioMarin announced the enzyme replacement therapy will cost $27,000 per biweekly infusion.
Beta blocker shows cancer-fighting properties
Beta blocker shows cancer-fighting properties
A new study finds that carvedilol, a drug typically used to treat high blood pressure, can protect against the sun-induced cell damage that leads to skin cancer.
FDA takes action against 14 companies for selling illegal cancer treatments
FDA takes action against 14 companies for selling illegal cancer treatments
The U.
White House says vote on healthcare plan may not come for weeks
White House says vote on healthcare plan may not come for weeks
WASHINGTON (Reuters) - A congressional vote on a Republican healthcare plan may not come for weeks as leaders in the House of Representatives and the Senate continue negotiations over possible...
Branded thiopeta shipped by Amneal
Branded thiopeta shipped by Amneal
PATERSON, N.
FDA approves Bayer's Stivarga to treat most common liver cancer
FDA approves Bayer's Stivarga to treat most common liver cancer
The U.
HIV market will see modest growth to $22.5 billion by 2025
HIV market will see modest growth to $22.5 billion by 2025
The human immunodeficiency virus (HIV) market across the nine major countries of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, and China, is set to grow from $16.
Generic Vytorin introduced by Teva
Generic Vytorin introduced by Teva
JERUSALEM, Israel — Teva Pharmaceutical Industries launched generic Vytorin (ezetimibe and simvastatin) tablets in the United States.
Cheap, widely available drug could stop thousands of mothers bleeding to death
Cheap, widely available drug could stop thousands of mothers bleeding to death
Haemorrhage after childbirth kills 100,000 women a year, mostly in low and middle-income countries.
Ovarian cancer market to more than quadruple to $5.2 billion by 2025
Ovarian cancer market to more than quadruple to $5.2 billion by 2025
The ovarian cancer space across the seven major markets of the US, France, Germany, Italy, Spain, the UK, and Japan, is set to rise from around $1.
New data shows effect of Biogen’s blockbuster MS drugs
New data shows effect of Biogen’s blockbuster MS drugs
US biotech Biogen (Nasdaq.
Fresenius Kabi to acquire Akorn for $4.3B
Fresenius Kabi to acquire Akorn for $4.3B
LAKE ZURICH, Ill.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand